HBK INVESTMENTS L P - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 154 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2014. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q4 2014$520,000
-54.4%
15,431
-52.6%
0.01%
-66.7%
Q3 2014$1,140,000
+34.8%
32,563
+26.5%
0.02%
+5.9%
Q2 2014$846,000
-10.3%
25,741
+4.7%
0.02%
-5.6%
Q4 2013$943,000
-26.1%
24,574
-47.2%
0.02%
-5.3%
Q3 2013$1,276,000
+4.6%
46,566
-19.9%
0.02%0.0%
Q2 2013$1,220,00058,1000.02%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q2 2014
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 241,186$9,353,00020.89%
Sensato Investors LLC 672,513$26,080,0005.62%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 2,781,889$107,882,0003.77%
Sloane Robinson LLP 57,500$2,230,0003.35%
Grandeur Peak Global Advisors, LLC 344,518$13,360,0002.83%
THOMAS WHITE INTERNATIONAL LTD 474,694$18,409,0002.58%
Granite Point Capital Management, L.P. 180,000$6,980,0002.56%
COMGEST GLOBAL INVESTORS S.A.S. 2,058,180$79,816,0002.49%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 234,071$9,077,0002.47%
DECADE CAPITAL MANAGEMENT LLC 389,735$15,114,0001.87%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders